State Street Corp Aura Biosciences, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 754,803 shares of AURA stock, worth $6.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
754,803
Previous 727,962 3.69%
Holding current value
$6.9 Million
Previous $5.5 Million 22.21%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.9 - $10.36 $185,202 - $278,072
26,841 Added 3.69%
754,803 $6.73 Million
Q2 2024

Aug 14, 2024
BUY
$6.81 - $7.89 $1.08 Million - $1.25 Million
158,158 Added 27.76%
727,962 $5.5 Million
Q1 2024

May 15, 2024
BUY
$7.09 - $9.24 $450,512 - $587,128
63,542 Added 12.55%
569,804 $4.47 Million
Q4 2023

Feb 14, 2024
BUY
$7.02 - $11.98 $343,292 - $585,845
48,902 Added 10.69%
506,262 $4.49 Million
Q3 2023

Nov 14, 2023
BUY
$8.97 - $12.38 $36,714 - $50,671
4,093 Added 0.9%
457,360 $4.1 Million
Q2 2023

Aug 14, 2023
BUY
$8.51 - $13.33 $891,099 - $1.4 Million
104,712 Added 30.04%
453,267 $5.6 Million
Q1 2023

May 15, 2023
BUY
$8.88 - $12.11 $336,241 - $458,545
37,865 Added 12.19%
348,555 $3.23 Million
Q4 2022

Feb 14, 2023
BUY
$9.86 - $14.59 $120,804 - $178,756
12,252 Added 4.11%
310,690 $3.26 Million
Q3 2022

Nov 15, 2022
BUY
$13.1 - $20.34 $546,165 - $848,015
41,692 Added 16.24%
298,438 $5.41 Million
Q2 2022

Aug 15, 2022
BUY
$12.37 - $21.86 $2.12 Million - $3.75 Million
171,764 Added 202.12%
256,746 $3.64 Million
Q1 2022

May 16, 2022
BUY
$15.94 - $23.34 $602,484 - $882,181
37,797 Added 80.1%
84,982 $1.87 Million
Q4 2021

Feb 14, 2022
BUY
$14.76 - $24.89 $696,450 - $1.17 Million
47,185 New
47,185 $801,000

Others Institutions Holding AURA

# of Institutions
85
Shares Held
37.6M
Call Options Held
122K
Put Options Held
38.5K
View Full List

About Aura Biosciences, Inc.

AURA Quotes by TradingView
  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $268M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email